
Celcuity Inc
CELCHealthcare|Biotechnology|USA
$107.58
-5.93 (-5.22%)
Tangible Book
$1.11
Earnings Power
$1.12
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
42.08,
408.28,
763.2,
1196.22,
1668.84
],
"ebit_estimate": [
-211.6,
-12.91,
229.77,
533.95,
853.86
],
"ebitda_estimate": [
-238.4,
-97.4,
null,
null,
null
],
"net_income_estimate": [
-217.33,
-15.59,
215.34,
499.88,
763.07
],
"per_share_eps_estimate": [
-4.02,
-0.77,
3.43,
7.68,
11.65
],
"eps_nri_estimate": [
-4.02,
-0.75,
3.39,
7.68,
11.65
],
"dividend_estimate": [
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-216,
-35.16,
201.74,
510.59,
892.24
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
75.25,
79.65,
84.37,
86.17,
88
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
31.4,
14,
9.23
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712",
"202803"
],
"revenue_estimate": [
null,
9.81,
32.28,
47.52,
65.23,
91.95,
117.42,
null
],
"ebit_estimate": [
-58.16,
-58.18,
-44.36,
-35.88,
-22.53,
11.3,
36,
null
],
"ebitda_estimate": [
-63,
-65.9,
-59,
-49.7,
-35.6,
-15.1,
3,
null
],
"net_income_estimate": [
-59.29,
-59.7,
-45.59,
-37.9,
-23.73,
9.32,
34.8,
null
],
"per_share_eps_estimate": [
-1.11,
-1.1,
-0.83,
-0.23,
-0.6,
-0.44,
0.11,
null
],
"eps_nri_estimate": [
-1.11,
-1.1,
-0.83,
-0.23,
-0.6,
-0.24,
0.11,
-0.55
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-58.57,
-59.28,
-45.41,
-37.9,
-23.73,
9.32,
-37.34,
null
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
null,
74.25,
75.5,
80,
81,
83,
83,
null
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
null,
null,
null,
null
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}